Short answer · Medically reviewed summary · Last updated: 2026-05-08
Congenital Sucrase-Isomaltase Deficiency (CSID) is classified under the ICD-10-CM code E74.39 (Other disorders of carbohydrate absorption). While the ICD-9-CM system is largely retired in clinical practice, CSID was historically coded under 271.3 (Intestinal disaccharidase deficiencies). What is the clinical significance of the CSID diagnostic codes? The use of specific ICD-10 coding for Congenital Sucrase-Isomaltase Deficiency is vital for ensuring patients receive appropriate medical coverage for diagnostic testing and specialized dietary management.
1 people with Congenital Sucrase Isomaltase Deficiency have shared their first-person experience on this question at DiseaseMaps.
Congenital Sucrase-Isomaltase Deficiency (CSID) is classified under the ICD-10-CM code E74.39 (Other disorders of carbohydrate absorption). While the ICD-9-CM system is largely retired in clinical practice, CSID was historically coded under 271.3 (Intestinal disaccharidase deficiencies).
The use of specific ICD-10 coding for Congenital Sucrase-Isomaltase Deficiency is vital for ensuring patients receive appropriate medical coverage for diagnostic testing and specialized dietary management. Because Congenital Sucrase-Isomaltase Deficiency is a rare genetic disorder characterized by a lack of the enzymes sucrase and isomaltase, accurate coding helps physicians track the long-term management of gastrointestinal symptoms, such as chronic diarrhea and abdominal bloating, which often mimic other conditions like Irritable Bowel Syndrome.
Diagnosis of Congenital Sucrase-Isomaltase Deficiency typically involves a combination of clinical assessment and specific testing. Because 140 members of the DiseaseMaps community have shared their experiences, we know that many patients face a long diagnostic journey. Common diagnostic approaches include:
Yes, Congenital Sucrase-Isomaltase Deficiency is an autosomal recessive disorder. This means that for a child to be born with the condition, they must inherit one mutated copy of the SI gene from each carrier parent. Genetic counseling is highly recommended for families navigating a diagnosis of Congenital Sucrase-Isomaltase Deficiency to understand recurrence risks and carrier status.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.